Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -0.23%170.77B | 3.23%702.08B | 4.39%171.16B | 2.70%680.09B | 2.85%165.68B | 1.63%182.2B | 1.49%168.25B | 5.07%163.97B | 9.87%662.2B | 8.18%161.1B |
| Cost of revenue | -0.64%139.11B | 2.84%575.85B | 3.13%140B | 1.20%559.95B | 2.08%136.52B | -0.55%148.83B | -0.24%138.85B | 3.82%135.75B | 10.57%553.33B | 7.19%133.73B |
| Gross profit | 1.60%31.66B | 5.06%126.23B | 10.44%31.16B | 10.35%120.15B | 6.58%29.17B | 12.68%33.37B | 10.52%29.4B | 11.54%28.21B | 6.48%108.87B | 13.26%27.36B |
| Operating expense | 6.26%22.96B | 5.62%87.91B | 6.54%21.61B | 9.61%83.23B | 11.78%22.04B | 10.23%20.98B | 7.31%19.93B | 8.97%20.28B | 7.20%75.93B | 6.61%19.72B |
| Staff costs | 8.43%8.06B | 5.61%30.24B | 6.00%7.43B | 10.57%28.63B | 9.78%7.29B | 9.18%7.27B | 9.30%7.06B | 14.26%7.01B | 2.95%25.89B | 3.67%6.64B |
| Selling and administrative expenses | 4.61%9.46B | 5.73%36.66B | 5.14%9.04B | 5.59%34.68B | 8.03%8.81B | 8.37%8.96B | 3.56%8.31B | 2.43%8.6B | 9.54%32.84B | 10.72%8.15B |
| -Selling and marketing expense | 17.32%1.96B | -1.05%6.51B | 10.97%1.67B | 39.07%6.58B | 41.20%1.81B | 80.32%1.92B | 52.38%1.35B | 0.13%1.5B | 2.58%4.73B | 31.72%1.28B |
| -General and administrative expense | 1.74%7.5B | 7.32%30.15B | 3.91%7.37B | -0.04%28.09B | 1.86%7B | -2.29%7.04B | -2.48%6.97B | 2.93%7.09B | 10.81%28.11B | 7.53%6.87B |
| Research and development costs | 0.00%504M | 12.15%2.21B | 10.77%504M | 3.96%1.97B | 13.56%561M | 3.01%479M | 1.29%472M | -2.57%455M | -2.42%1.89B | -23.65%494M |
| Rent and land expenses | 1.18%685M | 6.53%2.63B | 7.80%677M | 4.22%2.47B | 0.50%600M | 4.71%623M | 5.66%616M | 6.08%628M | 9.13%2.37B | 9.54%597M |
| Other operating expenses | 7.58%4.26B | 4.42%16.18B | 10.19%3.96B | 19.69%15.49B | 24.75%4.78B | 19.72%3.65B | 14.22%3.46B | 18.72%3.59B | 11.64%12.94B | 8.49%3.84B |
| Operating profit | -8.93%8.7B | 3.80%38.32B | 20.40%9.55B | 12.07%36.92B | -6.83%7.13B | 17.08%12.39B | 17.94%9.48B | 18.69%7.93B | 4.86%32.94B | 34.93%7.65B |
| Net non-operating interest income (expenses) | -138.46%-186M | -4.59%-524M | 52.15%-78M | 14.51%-501M | 43.29%-93M | 17.69%-121M | 8.15%-124M | -16.43%-163M | -14.23%-586M | -45.13%-164M |
| Non-operating interest income | -9.09%140M | 62.86%627M | 129.85%154M | 91.54%385M | 97.14%138M | 94.23%101M | 68.09%79M | 109.38%67M | 89.62%201M | 79.49%70M |
| Non-operating interest expense | 40.52%326M | 29.91%1.15B | 0.87%232M | 12.58%886M | -1.28%231M | 11.56%222M | 11.54%203M | 33.72%230M | 27.14%787M | 53.95%234M |
| Net investment income | 25.61%716M | 27.25%1.12B | 20.76%570M | 35.76%877M | 149.57%58M | 12.68%320M | -50.91%27M | 11.32%472M | -10.90%646M | -735.71%-117M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 157.89%343M | -80.27%133M | 0 | -92.75%34M | -82.82%674M | -94.30%151M | ||||
| Income from associates and other participating interests | -28.80%89M | -22.21%536M | -16.11%125M | 135.96%689M | 47.73%65M | -1.27%234M | 1,908.33%241M | 15,000.00%149M | 151.72%292M | 393.33%44M |
| Special income (charges) | -167.96%-552M | -94.14%-2.39B | 45.36%-206M | -8.38%-1.23B | -12.27%-540M | 25.83%-382M | -35.19%70M | -53.25%-377M | -134.30%-1.13B | 20.76%-481M |
| Less:Restructuring and mergern&acquisition | ---- | --0 | ---- | -0.74%-547M | --0 | --0 | ---- | ---- | ---543M | --0 |
| Less:Other special charges | 92.08%388M | 54.30%1.92B | -46.42%202M | 4.62%1.25B | -56.22%204M | 43.27%351M | 23.72%313M | 66.81%377M | 313.19%1.19B | -9.51%466M |
| Less:Write off | 4,000.00%164M | -12.43%465M | --4M | 9.03%531M | 2,140.00%336M | -88.52%31M | -9.89%164M | --0 | 148.47%487M | -83.70%15M |
| Other non-operating income (expenses) | -93.06%12M | 56.12%434M | 393.22%173M | 73.75%278M | -41.86%150M | 83.52%-30M | 239.06%217M | -395.00%-59M | 322.22%160M | 126.32%258M |
| Income before tax | -13.41%8.77B | 1.82%37.84B | 27.43%10.12B | 12.65%37.16B | -7.80%6.77B | 16.05%12.44B | 22.09%10.01B | 18.04%7.95B | -6.04%32.99B | -4.47%7.34B |
| Income tax | -21.92%2.43B | -4.18%10.79B | 10.32%3.11B | 20.39%11.26B | -11.37%1.93B | 20.40%3.57B | 29.81%2.94B | 44.82%2.82B | -13.75%9.35B | -3.29%2.17B |
| Net income | -9.64%6.34B | 4.42%27.05B | 36.85%7.01B | 9.59%25.9B | -6.31%4.84B | 14.38%8.88B | 19.15%7.06B | 7.13%5.12B | -2.60%23.64B | -4.95%5.17B |
| Net income continuous operations | -9.64%6.34B | 4.42%27.05B | 36.85%7.01B | 9.59%25.91B | -6.29%4.84B | 14.39%8.88B | 19.13%7.06B | 7.13%5.12B | -2.60%23.64B | -4.95%5.17B |
| Noncontrolling interests | 21.16%687M | 64.51%2.32B | 254.38%567M | -31.90%1.41B | 1.42%430M | -33.92%485M | -11.87%334M | -69.92%160M | 133.52%2.07B | 103.85%424M |
| Net income attributable to the company | -12.35%5.65B | 0.96%24.73B | 29.81%6.44B | 13.57%24.5B | -6.98%4.41B | 19.44%8.39B | 21.25%6.73B | 16.77%4.96B | -7.76%21.57B | -9.30%4.74B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -12.35%5.65B | 0.96%24.73B | 29.81%6.44B | 13.57%24.5B | -6.98%4.41B | 19.44%8.39B | 21.25%6.73B | 16.77%4.96B | -7.76%21.57B | -9.30%4.74B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -10.66%22.54 | 1.51%97.35 | 29.78%25.23 | 14.75%95.9 | -6.93%17.27 | 20.88%32.855 | 22.95%26.335 | 18.43%19.44 | -5.42%83.57 | -7.80%18.555 |
| Diluted earnings per share | -10.66%22.54 | 1.51%97.35 | 29.78%25.23 | 14.75%95.9 | -6.94%17.268 | 20.88%32.855 | 22.96%26.3301 | 18.43%19.44 | -5.42%83.57 | -7.80%18.555 |
| Dividend per share | 0 | 24.32%46 | 0 | 42.31%37 | 42.31%18.5 | 0 | 42.31%18.5 | 0 | 4.00%26 | 4.00%13 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |